Literature DB >> 9582018

Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner.

H Sawa1, T A Ohshima, H Ukita, H Murakami, Y Chiba, H Kamada, M Hara, I Saito.   

Abstract

Alternative splicing of cyclin D1 gene mRNA has recently been demonstrated. The novel transcript shows no splicing at the downstream exon 4 boundary and encodes a protein with an altered carboxyl-terminal domain that is a cyclin D1 variant; exon 5 is not included in the coding sequence which terminates downstream of exon 4. We here produced cells that exogenously express each form of cyclin D1 and analysed their cell cycle regulation. We found that (1) alternative splicing forms of cyclin D1 modulated entry into the cell cycle in an inverse manner; (2) both splicing forms suppressed cell growth; and (3) cells overexpressing form [a] were inhibited from entry into and completion of the S phase, although form [b]-expressing cells showed no reduction of G1- to S transition. We also found that overexpression of either cyclin D1 form upregulated Rb gene products, suggesting that this upregulation may be one of the causes of growth suppression in cyclin D1 overexpressing cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582018     DOI: 10.1038/sj.onc.1201691

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

Review 1.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

2.  CYP17 polymorphisms and prostate cancer outcomes.

Authors:  Jonathan L Wright; Erika M Kwon; Daniel W Lin; Suzanne Kolb; Joseph S Koopmeiners; Ziding Feng; Elaine A Ostrander; Janet L Stanford
Journal:  Prostate       Date:  2010-07-01       Impact factor: 4.104

3.  Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Authors:  Christopher E Aston; David A Ralph; Dominique P Lalo; Sharmila Manjeshwar; Bobby A Gramling; Daniele C DeFreese; Amy D West; Dannielle E Branam; Linda F Thompson; Melissa A Craft; Debra S Mitchell; Craig D Shimasaki; John J Mulvihill; Eldon R Jupe
Journal:  Hum Genet       Date:  2004-12-21       Impact factor: 4.132

4.  Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population.

Authors:  Jing Jiang; Jingweng Wang; Sadao Suzuki; Vendhan Gajalakshmi; Kiyonori Kuriki; Yang Zhao; Seiichi Nakamura; Susumu Akasaka; Hideki Ishikawa; Shinkan Tokudome
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-03       Impact factor: 4.553

5.  CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.

Authors:  Jing Ni; Meilin Wang; Miaomiao Wang; Shilong Fu; Delan Zhou; Zhengdong Zhang; Suping Han
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

6.  Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population.

Authors:  Xuwei Hou; Sili Wang; Yuling Zhou; Ziliang Xu; Yao Zou; Xiaofan Zhu; Mingzhe Han; Tianxiang Pang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

7.  Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.

Authors:  Hailiang Zong; Lei Cao; Chong Ma; Jianping Zhao; Xing Ming; Ming Shang; Hongsheng Xu
Journal:  Tumour Biol       Date:  2014-05-20

8.  Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.

Authors:  Malgorzata Rydzanicz; Pawel Golusinski; Daniela Mielcarek-Kuchta; Wojciech Golusinski; Krzysztof Szyfter
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-29       Impact factor: 2.503

9.  Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.

Authors:  Vanita K Gupta; Andrew Feber; Liqiang Xi; Arjun Pennathur; Maoxin Wu; James D Luketich; Tony E Godfrey
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

10.  Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome.

Authors:  Jinyun Chen; Carol J Etzel; Christopher I Amos; Qing Zhang; Nancy Viscofsky; Noralane M Lindor; Patrick M Lynch; Marsha L Frazier
Journal:  Cancer Causes Control       Date:  2009-08-19       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.